Shanghai HeartCare Medical Technology Corporation Limited
Shanghai HeartCare Medical Technology Corporation Limited, commonly referred to as HeartCare, is a leading player in the medical technology industry, headquartered in Shanghai, China. Founded in 2005, the company has established itself as a pioneer in cardiovascular health solutions, focusing on innovative diagnostic and therapeutic devices. HeartCare's core offerings include advanced cardiac monitoring systems and minimally invasive surgical tools, designed to enhance patient outcomes and streamline healthcare processes. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in the medical community. With a strong presence in Asia and expanding operations globally, HeartCare has achieved significant milestones, including numerous patents and collaborations with top-tier medical institutions. Its dedication to advancing heart health technology continues to solidify its market position as a frontrunner in the field.
DitchCarbon Score
How does Shanghai HeartCare Medical Technology Corporation Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai HeartCare Medical Technology Corporation Limited's score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shanghai HeartCare Medical Technology Corporation Limited's reported carbon emissions
In 2023, Shanghai HeartCare Medical Technology Corporation Limited reported total carbon emissions of approximately 5,000,000 kg CO2e. This figure includes 7,430 kg CO2e from Scope 1 emissions, 2,522,600 kg CO2e from Scope 2 emissions, and 2,530,000 kg CO2e from Scope 3 emissions. Despite the significant emissions, the company has not disclosed any specific reduction targets or initiatives aimed at decreasing its carbon footprint. This lack of defined climate commitments may reflect broader industry challenges in addressing climate change effectively. As a medical technology corporation headquartered in China, Shanghai HeartCare is positioned within a sector that increasingly faces scrutiny regarding sustainability practices and carbon management. The absence of a climate pledge or reduction targets suggests an opportunity for the company to enhance its environmental strategy and align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 7,430 |
| Scope 2 | 2,522,600 |
| Scope 3 | 2,530,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai HeartCare Medical Technology Corporation Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
